Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $17.3 Million - $20.7 Million
-125,000 Reduced 52.3%
114,000 $18.4 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $10.9 Million - $12.5 Million
-81,313 Reduced 25.39%
239,000 $32.1 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $5.13 Million - $6.37 Million
-38,900 Reduced 10.83%
320,313 $51.9 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $4.14 Million - $4.7 Million
38,900 Added 12.14%
359,213 $38.7 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $1.69 Million - $2.28 Million
21,000 Added 7.02%
320,313 $34.3 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $4.28 Million - $5.03 Million
-49,855 Reduced 14.28%
299,313 $26.2 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $4.09 Million - $5.48 Million
55,813 Added 19.03%
349,168 $34.3 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $3.15 Million - $4.78 Million
48,855 Added 19.98%
293,355 $22.4 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $4.18 Million - $5.23 Million
58,000 Added 31.1%
244,500 $21.6 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $3.65 Million - $4.38 Million
-57,900 Reduced 23.69%
186,500 $14.1 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $328,500 - $419,900
-5,000 Reduced 2.0%
244,400 $17.8 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $2.55 Million - $3 Million
33,000 Added 15.25%
249,400 $20.1 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $4.67 Million - $5.76 Million
-60,000 Reduced 21.71%
216,400 $20 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $1.51 Million - $1.68 Million
-17,000 Reduced 5.79%
276,400 $26.1 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $2.31 Million - $2.73 Million
25,700 Added 9.6%
293,400 $27.2 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $5.93 Million - $7.93 Million
-64,400 Reduced 19.39%
267,700 $25.3 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $7.43 Million - $8.15 Million
83,000 Added 33.32%
332,100 $32.1 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $2.86 Million - $3.66 Million
41,000 Added 19.7%
249,100 $22.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
208,100
208,100 $15.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.